Clinical Trial Update: Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

The University of Arizona-sponsored Phase 1/2 trial of Abraxane plus temozolomide and bevacizumab for metastatic melanoma with brain metastases has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Arizona | Conditions: Metastatic Melanoma, Brain Metastases | Phase 1, Phase 2 | Status: WITHDRAWN